Journal
POLYMER CHEMISTRY
Volume 11, Issue 44, Pages 7078-7086Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0py00987c
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [51673188, 21975246]
- Major Project of Scientific and Technological of Henan Province [201701033]
- Natural Science Foundation of Shandong Province [ZR2018BB050]
Ask authors/readers for more resources
Biodegradable polymeric nanoparticles have attracted much attention in chemotherapy. However, premature drug release before reaching the target tissues and insufficient drug release within the target cells limit their further application. In this study, reduction-sensitive disulfide linkage core-cross-linked polymeric (mPEG(2k)-b-PLL/LA) micelles were developed. Doxorubicin (DOX) as a model drug was encapsulated into the micelles. After core-cross-linking, the DOX-loaded polymeric micelles (CLM@DOX) can avoid premature drug release in the physiological environment and be triggered to dissociate in response to a high level of reductants of cancer cells. As expected, the reduction-sensitive CLM@DOX can rapidly release the drug intracellularly and lead to enhanced growth inhibition against glutathione-pretreated cancer cells. Notably, CLM@DOX exhibited the best in vivo antitumor capacity and reduced system toxicity compared with those of free DOX and uncross-linked UCLM@DOX groups, suggesting that this polymeric nanoparticle may have the potential to be applied as an effective site-specific drug delivery system for cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available